Page Tools:

Modern Pharmaceutical Industry: A Primer

Author(s): Thomas M. Jacobsen, PharmD, MS, Manager, US Regulatory Affairs, Teva Neuroscience
Albert I. Wertheimer, PhD, RPh, MBA, Director, Center for Pharmaceutical Health Services Research, Temple University School of Pharmacy
Details:
  • ISBN-13: 9780763766368
  • Hardcover    320 pages      © 2010
Price: $175.95 US List
Add to Cart

Modern Pharmaceutical Industry: A Primer comprehensively explains the broad range of divisions in the complex pharmaceutical industry. Experts actively involved in each component discuss their own contribution to a pharmaceutical company's work and success. Divisions include regulatory affairs, research and development, intellectual property, pricing, marketing, generics, OTC, and more.  The seventeen chapters included in this resource offer a wide range of topics, from discovery and formulation to post-approval and legal. Readers will be given a detailed look at the structure of a contemporary drug company and a thorough understanding of what goes on behind the scenes.

Modern Pharmaceutical Industry: A Primer is a valuable resource for all pharmacy students, new hires at pharmaceutical companies, drug company management, and academic health center libraries. No other text provides a comprehensive look at one of the most dynamic industries related to the modern healthcare system.

Chapter  1  Drug Discovery: New Compounds
Chapter  2  Pharmaceutical Formulation
Chapter  3  Analytical Testing and Development
Chapter  4  Manufacturing and Production
Chapter  5  Ethics in Clinical Research
Chapter  6  Clinical Research
Chapter  7  Regulatory Affairs
Chapter  8  Medical Information
Chapter  9  Drug Safety and Pharmacovigilance
Chapter  10  Legal and Intellectual Property
Chapter  11  Sales and Marketing
Chapter  12  Finance
Chapter  13  Pharmacoeconomics and Outcomes Research
Chapter  14  Public Affairs
Chapter  15  Generic Drugs
Chapter  16  Over-the-Counter Drugs
Chapter  17  Future Industry Trends

Thomas M. Jacobsen, PharmD, MS-Manager, US Regulatory Affairs, Teva Neuroscience

Albert I. Wertheimer, PhD, RPh, MBA-Director, Center for Pharmaceutical Health Services Research, Temple University School of Pharmacy